The Pharma Data

AUGUST 11, 2020

The treatment is already available on an emergency basis for people suffering with severe symptoms from coronavirus. It has not received general approval to treat the virus in the US, but has in several European countries and Japan. Gilead Sciences has asked the FDA to approve its drug remdesivir to treat COVID-19 patients.

FDA Approval 52

FDA Approval FDA Government Virus 52

The Pharma Data

SEPTEMBER 7, 2020

‘I just want my life back’ The government moved away from community testing on 12 March, instead only testing those admitted to hospital. The government is simply not doing enough with the existing medical expertise. However, many of these people may not have been tested for Covid. ” Person-centred rehab.

Doctors 52

Doctors Treatment Hospitals Government 52

The Pharma Data

OCTOBER 22, 2020

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication of SARS-CoV-2, the virus that causes COVID-19.

FDA Approval 52

FDA Approval Treatment FDA Hospitals 52

Drug Target Review

APRIL 17, 2024

What are the potential implications of the research findings for cancer risk assessment, prevention strategies, and treatment approaches? HLA are the critical molecules that our immune systems use to present peptides to T cells and facilitate recognition and killing in immune responses to pathogens.

Immune Response 105

Immune Response Laboratories DNA Virus 105

The Pharma Data

SEPTEMBER 28, 2020

The NHS is facing a “triple whammy” of rising Covid-19 cases, a major backlog in treatment and reduced capacity due to infection-control measures, according to health bosses. The NHS bosses also called on ministers to be “honest and realistic” about waiting lists for treatment.

Nurses 52

Nurses Virus Hospitals Treatment 52

The Pharma Data

OCTOBER 28, 2020

Food and Drug Administration as part of its review of our Emergency Use Authorization submission, and we continue to focus on completing our ongoing trials evaluating REGN-COV2 for the treatment and prevention of COVID-19.” Serious adverse events were numerically more frequent with placebo than REGN-COV2 treatment (0.8%

Virus 40

Virus Trials Clinical Trials Production 40

The Pharma Data

DECEMBER 21, 2020

(Nasdaq:BCRX) today announced that data from part 1 of a clinical trial of its broad-spectrum antiviral, galidesivir, showed that galidesivir was safe and generally well tolerated in patients infected with SARS-CoV-2, the virus that causes COVID-19. It is in advanced development for the treatment of Marburg virus disease.

Clinical Trials 52

Clinical Trials Virus RNA Trials 52

The Pharma Data

AUGUST 18, 2020

REGN-COV2 is Regeneron’s two-antibody combination currently in late-stage clinical trials for the treatment and prevention of COVID-19 infection. We are excited about the potential for one medicine to serve both as a treatment for those infected as well as protection for people exposed to the virus. and around the world.

Clinical Trials 52

Clinical Trials Virus Trials Treatment 52

The Pharma Data

DECEMBER 30, 2020

The Company aims to supply millions of doses in the first quarter as part of an agreement with the government to supply up to 100 million doses in total. We would like to thank our many colleagues at AstraZeneca, Oxford University, the UK government and the tens of thousands of clinical trial participants.”.

Vaccine 52

Vaccine Clinical Trials Virus Trials 52

The Pharma Data

SEPTEMBER 1, 2020

Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions. This can help healthcare professionals identify a SARS-CoV-2 infection in people suspected to carry the virus with results typically ready in 15 minutes.

Virus 52

Virus Laboratories Clinical Trials Treatment 52

The Pharma Data

DECEMBER 10, 2020

In the study, immunization with the hAd5-COVID-19 vaccine inhibited SARS-CoV-2 virus replication in 100% (10 of 10) of Rhesus macaques, with a drop in viral replication starting on the first day of vaccine administration, and undetectable viral levels as early as three to five days post-challenge in most of the animals.

Vaccine 52

Vaccine Immune Response Virus Clinical Trials 52

The Pharma Data

OCTOBER 30, 2020

NASDAQ: REGN) received today a recommendation from the independent data monitoring committee (IDMC) for the REGN-COV2 antibody cocktail treatment trials for COVID-19 that the current hospitalized patient trial be modified. TARRYTOWN, N.Y. , Regeneron Pharmaceuticals, Inc.

Hospitals 52

Hospitals Virus Production Clinical Trials 52

The Pharma Data

SEPTEMBER 9, 2020

The government says there is “high demand” for coronavirus tests. It means we are able to look more closely for virus circulating in the community than we were when mass testing first started. The increase in testing capacity means the government now has a flexible army of testing facilities. Image copyright.

Hospitals 52

Hospitals Virus Government Treatment 52

The Pharma Data

JANUARY 29, 2021

AstraZeneca continues to engage with governments, international organisations and collaborators around the world to ensure broad and equitable access to the vaccine at no profit for the duration of the pandemic.

Vaccine 52

Vaccine Clinical Trials Virus Trials 52

The Pharma Data

JANUARY 29, 2021

AstraZeneca continues to engage with governments, international organisations and collaborators around the world to ensure broad and equitable access to the vaccine at no profit for the duration of the pandemic.

Vaccine 52

Vaccine Clinical Trials Virus Trials 52

The Pharma Data

SEPTEMBER 2, 2020

The government said it was working closely with local authorities “in response to the changing situation” Mr Burnham urged people in Bolton and Trafford to “continue to follow the guidance” not to have social gatherings at home. Book close contact services such as facials and brow or eyelash treatments.

Government 52

Government Virus Treatment 52

The Pharma Data

AUGUST 21, 2020

Regeneron claims REGN-COV2, which is currently being studied in two Phase 2/3 clinical trials, provides a much-needed treatment option for Covid-19 that has the potential to prevent infection and thus slow down the spread of the pandemic on a global scale. REGN -COV2 could be a critical line of defense against the Covid-19 pandemic.”.

Vaccine 52

Vaccine Pharmacy Clinical Trials Virus 52

The Pharma Data

OCTOBER 6, 2021

A booster dose of the vaccine elicited significantly higher neutralizing antibody titers against the initial SARS-CoV-2 virus (wild type), as well as the Beta and Delta variants, when compared with the levels observed after the two-dose primary series.

Vaccine 52

Vaccine Small Molecule Government Therapies 52

Common Sense for Drug Policy Blog

JANUARY 1, 2024

18 The average cost of a hepatitis A–related hospitalization in 2016 was $16 610, and recent hepatitis A virus outbreaks alone have cost the nation at least $270 million since 2016. 19 In 2019, HIV care and treatment cost the US government more than $20 billion.

Virus 40

Virus Government Hospitals Treatment 40

The Pharma Data

NOVEMBER 23, 2020

AstraZeneca continues to engage with governments, multilateral organisations and collaborators around the world to ensure broad and equitable access to the vaccine at no profit for the duration of the pandemic. Participants receive one or two intramuscular doses of a half dose (~2.5 AstraZeneca.

Vaccine 52

Vaccine Virus Trials Clinical Trials 52

The Pharma Data

AUGUST 17, 2020

The UK government is imposing stricter regulations on the sale of laxatives, to help prevent their misuse. Products available for general sale (in shops and supermarkets) will be limited to a pack size equivalent to two short treatment courses (up to 20 standard-strength tablets, 10 maximum-strength tablets or 100ml solution/syrup).

Pharmacy 52

Pharmacy Virus Production Government 52

The Pharma Data

MAY 4, 2021

A Psychedelic Drug Passes a Big Test for PTSD Treatment ( NYTimes ) ( Endpoints ). WHO is closely monitoring 10 Covid variants as virus mutates around the world ( CNBC ) . Can a topical treatment beat blockbuster eye injectables? . Government, Regulatory & Legal.

Vaccine 52

Vaccine FDA Approval FDA Licensing 52

The Pharma Data

DECEMBER 17, 2020

These follow-on data provided the first definitive prospective evidence demonstrating anti-viral activity for a treatment regimen now available for COVID-19, and also further documented the ability of this treatment to decrease the need for further medical attention,” said George D. Yancopoulos , M.D.,

Hospitals 52

Hospitals Production Clinical Trials Virus 52

The Pharma Data

APRIL 3, 2021

The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints. About the ITAC Trial.

Clinical Trials 52

Clinical Trials Trials Hospitals Treatment 52

The Pharma Data

APRIL 15, 2022

These data reinforce the potential function of a third dose of the vaccine in maintaining high levels of protection against the virus in this age group. The neutralizing GMT against the wild-type virus was 2153 (after three doses), compared to 335 after two doses.

Immune Response 52

Immune Response Vaccine Clinical Trials Virus 52

The Pharma Data

JANUARY 3, 2021

InspirMed is a newly established subsidiary of TLC specializing in the development of inhalable liposome formulation programs, such as TLC19 for the treatment of Coronavirus disease 2019 (COVID-19) as well as other programs for severe acute and chronic pulmonary diseases. SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Jan.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Disease 52

DrugBank

JANUARY 29, 2025

In certain cancers, the overexpression or constitutive activation of oncogenes , such as HER2, KRAS, or BRAF, can drive tumorigenesis by dysregulating key signaling pathways that govern cell growth, survival, and differentiation. Adeno-associated viruses (AAV) and lentiviruses are the most commonly used viral vectors in gene therapy trials.

Therapies 52

Therapies DNA RNA Disease 52

The Pharma Data

AUGUST 7, 2020

Doctors’ bodies have stressed the need to make sure the NHS can access beds, with millions waiting for treatment. Protecting the NHS from collapse became one of the government’s main priorities. CARE HOMES: The forgotten frontline struggling to protect residents against the killer virus. Source link.

Hospitals 52

Hospitals Doctors Virus Government 52

The Pharma Data

OCTOBER 14, 2020

The research is part of an ongoing collaboration between Columbia University and Tonix that focuses on T cell and antibody responses to SARS-CoV-2 (CoV-2), the virus that causes COVID-19. solution), which is in Phase 2 development for the treatment of life-threatening cocaine intoxication and has FDA Breakthrough Therapy designation.

Vaccine 40

Vaccine Pharmaceuticals Small Molecule Virus 40

The Pharma Data

NOVEMBER 9, 2020

All aspects of the collaboration are under the oversight of joint governing bodies. The trial comprised a five to six week screening period, a 52-week treatment period and a 12-week post-treatment follow-up period. The primary efficacy endpoint was the annualized asthma exacerbation rate during the 52-week treatment period.

Trials 52

Trials Production Clinical Trials Government 52

Agency IQ

SEPTEMBER 6, 2023

SEP 6, 2023 11:58 AM CDT Regulatory background The Federal Insecticide, Fungicide, and Rodenticide Act ( FIFRA ) governs the registration, distribution, sale, and use of pesticides in the U.S. Commenters also provided edits to both the virus and bacterial methods, as well as the claim and use sites. BY PATRICIA ISCARO, ESQ.

Production 40

Production Virus Long-Term Care Facilities Laboratories 40

The Pharma Data

SEPTEMBER 17, 2020

Lilly is currently studying several potential neutralizing antibodies for the prevention and/or treatment of COVID-19 as either monotherapy or in combination. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities.

Therapies 52

Therapies Production Government Disease 52

The Pharma Data

SEPTEMBER 29, 2020

When lockdown ended, the government’s priority was to get people back on the high street, and of course businesses badly needed their support. He picked up the virus right at the start of the pandemic and had a relentless and gruelling illness followed by a lingering debilitation that has lasted over six months. Source link.

Doctors 52

Doctors Trials Virus Government 52

The Pharma Data

FEBRUARY 22, 2021

government in order to accelerate its development and manufacturing. The recombinant technology combined with GSK’s adjuvant could offer the advantages of stability at temperatures used for routine vaccines, the ability to generate high and sustained immune responses, and the potential to prevent virus transmission.

Vaccine 52

Vaccine Immune Response Trials Clinical Trials 52

The Pharma Data

JUNE 25, 2021

. “These data show consistent, high levels of efficacy and reaffirm the ability of the vaccine to prevent COVID-19 amid ongoing genetic evolution of the virus. Government.” Variant Virus Strains. against the original virus strain, 86.3% ” Results: Consistent, high efficacy among circulating variants.

Vaccine 40

Vaccine Trials Disease Immune Response 40

The Pharma Data

JUNE 1, 2022

Anderson has led the team of infectious disease biologists that validated and delivered to an emergency use authorization PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), Pfizer’s novel COVID-19 oral treatment.

Vaccine 40

Vaccine Research Doctors Laboratories 40

The Pharma Data

SEPTEMBER 5, 2021

1 Tezepelumab is a potential first-in-class treatment that acts at the top of the inflammatory cascade by targeting thymic stromal lymphopoietin (TSLP), an epithelial cytokine, and has the potential to treat a broad population of patients with severe asthma. 7,8,9 Uncontrolled asthma occurs when symptoms persist despite treatment.

Trials 52

Trials Clinical Trials Therapies Treatment 52